<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2022.843576</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Glomerular Expression of S100A8 in Lupus Nephritis: An Integrated Bioinformatics Analysis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Qijiao</surname><given-names>Wei</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1612877"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhihan</surname><given-names>Chen</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Makota</surname><given-names>Panashe</given-names>
</name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qing</surname><given-names>Yan</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fei</surname><given-names>Gao</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhihong</surname><given-names>Wang</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>He</surname><given-names>Lin</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Fujian Provincial Hospital</institution>, <addr-line>Fuzhou</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Fujian Medical University Provincial Clinical Medical College</institution>, <addr-line>Fuzhou</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Nancy Agmon-Levin, Sheba Medical Center, Israel</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Arif Ali, Shanghai Jiao Tong University, China; Tianfu Wu, University of Houston, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Chen Zhihan, <email xlink:href="mailto:1377037010@qq.com">1377037010@qq.com</email>; Lin He, <email xlink:href="mailto:linhe0086@163.com">linhe0086@163.com</email>; Wang Zhihong, <email xlink:href="mailto:56137170@qq.com">56137170@qq.com</email>
</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Autoimmune and Autoinflammatory Disorders, a section of the journal Frontiers in Immunology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>27</day>
<month>04</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>843576</elocation-id>
<history>
<date date-type="received">
<day>26</day>
<month>12</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>03</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Qijiao, Zhihan, Makota, Qing, Fei, Zhihong and He</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Qijiao, Zhihan, Makota, Qing, Fei, Zhihong and He</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>Lupus nephritis (LN) is a major risk factor of morbidity and mortality. Glomerular injury is associated with different pathogeneses and clinical presentations in LN patients. However, the molecular mechanisms involved are not well understood. This study aimed to explore the molecular characteristics and mechanisms of this disease using bioinformatics analysis.</p>
</sec>
<sec>
<title>Methods</title>
<p>To characterize glomeruli in LN, microarray datasets GSE113342 and GSE32591 were downloaded from the Gene Expression Omnibus database and analyzed to determine the differentially expressed genes (DEGs) between LN glomeruli and normal glomeruli. Functional enrichment analyses and protein&#x2013;protein interaction network analyses were then performed. Module analysis was performed using the Search Tool for the Retrieval of Interacting Genes/Proteins and Cytoscape software. Immunofluorescence staining was performed to identify the glomerular expression of S100A8 in various International Society of Nephrology/Renal Pathology Society (ISN/RPS) class LN patients. The image of each glomerulus was acquired using a digital imaging system, and the green fluorescence intensity was quantified using Image-Pro Plus software.</p>
</sec>
<sec>
<title>Results</title>
<p>A total of 13 DEGs, consisting of 12 downregulated genes and one upregulated gene (S100A8), were identified in the microarray datasets. The functions and pathways associated with the DEGs mainly include inflammatory response, innate immune response, neutrophil chemotaxis, leukocyte migration, cell adhesion, cell&#x2013;cell signaling, and infection. We also found that monocytes and activated natural killer cells were upregulated in both GSE113342 and GSE32591. Glomerular S100A8 staining was significantly enhanced compared to that in the controls, especially in class IV.</p>
</sec>
<sec>
<title>Conclusions</title>
<p>The DEGs identified in the present study help us understand the underlying molecular mechanisms of LN. Our results show that glomerular S100A8 expression varies in different pathological types; however, further research is required to confirm the role of S100A8 in LN.</p>
</sec>
</abstract>
<kwd-group>
<kwd>lupus nephritis</kwd>
<kwd>differentially expressed genes</kwd>
<kwd>microarray</kwd>
<kwd>immunofluorescence</kwd>
<kwd>S100A8</kwd>
</kwd-group>
<contract-num rid="cn001">No.2019J01184, No.2021J05056</contract-num>
<contract-sponsor id="cn001">Natural Science Foundation of Fujian Province<named-content content-type="fundref-id">10.13039/501100003392</named-content>
</contract-sponsor>
<counts>
<fig-count count="7"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="39"/>
<page-count count="11"/>
<word-count count="4333"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Biographical Note</title>
<p>We use a bioinformatics method to obtain the DEGs between LN glomerulus and normal glomerulus and performed immunofluorescence staining to identify the expression of S100A8 in various ISN/RPS class LN patients.</p>
</sec>
<sec id="s2">
<title>Significance and Innovations</title>
<list list-type="simple">
<list-item>
<p>&#x27a3;Monocytes and activated NK cells were upregulated in LN glomerulus.</p>
</list-item>
<list-item>
<p>&#x27a3;Glomerular S100A8 is different in different pathological types.</p>
</list-item>
<list-item>
<p>&#x27a3;The glomerular S100A8 staining was obviously enhanced compared with the controls, especially in class IV.</p>
</list-item>
</list>
</sec>
<sec id="s3">
<title>Introduction</title>
<p>Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by immune inflammation, which can affect multiple organs. It is known to affect the kidneys in approximately 50% of patients (<xref ref-type="bibr" rid="B1">1</xref>). Lupus nephritis (LN) is a major risk factor of morbidity and mortality. It was found that glomerular injury, including that of mesangial cells, endothelial cells, and podocytes, is associated with different pathogeneses and clinical presentations in LN patients (<xref ref-type="bibr" rid="B2">2</xref>). Intense efforts have been made to elucidate the pathogenesis and molecular mechanisms of LN; however, they are still not well understood (<xref ref-type="bibr" rid="B3">3</xref>). Therefore, it is necessary to further explore the molecular characteristics and mechanisms of the disease. To characterize glomeruli in LN using bioinformatics analysis, microarray datasets GSE113342 and GSE32591 were downloaded from the Gene Expression Omnibus (GEO) database and analyzed to determine the differentially expressed genes (DEGs) between the LN glomerulus and normal glomerulus. Functional enrichment analyses and protein&#x2013;protein interaction (PPI) network analyses were then performed. Module analysis was performed using the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) and Cytoscape software.</p>
<p>S100A8 was identified as one of the 13 DEGs. However, its mRNA expression was different in the abovementioned two microarray datasets. S100A8 (also known as MRP8) is a calcium-binding protein belonging to the S100 family (<xref ref-type="bibr" rid="B4">4</xref>). It is mainly expressed in granulocytes and mononuclear blood cells, such as neutrophils and macrophages (<xref ref-type="bibr" rid="B5">5</xref>). S100A8 is expressed in various autoimmune diseases, such as systemic sclerosis, psoriasis, dermatomyositis, and Sjogren&#x2019;s syndrome (<xref ref-type="bibr" rid="B6">6</xref>). Some studies have also found that serum and urine S100A8 levels are elevated in patients with LN (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>). To our knowledge, the glomerular expression of S100A8 in various ISN/RPS class LN patients is unknown. In this study, immunofluorescence staining and semiquantitative analysis were performed, and the relationship between glomerular expression of S100A8 and clinical data, such as disease activity or urinary protein measurements, was explored.</p>
</sec>
<sec id="s4">
<title>Methods</title>
<sec id="s4_1">
<title>Microarray Data</title>
<p>NCBI GEO (<uri xlink:href="http://www.ncbi.nlm.nih.gov/geo">http://www.ncbi.nlm.nih.gov/geo</uri>) (<xref ref-type="bibr" rid="B9">9</xref>) is a public functional genomics data repository with high-throughput gene expression data, chips, and microarrays. We used &#x201c;lupus nephritis&#x201d; (keywords) to search, and there were 335 results in the GEO Database. Then, we selected <italic>Homo sapiens</italic>, and 301 results were left. We browsed 301 links in detail. In this study, we want to explore the DEGs between LN glomerulus and normal glomerulus. In the first step, we selected LN kidney samples. And only 5 datasets were left. They were GSE112943, GSE127797, GSE113342, GSE32591, and GSE69438. Then, only glomeruli and tubulointerstitium separated samples were what we needed, and GSE113342 and GSE32591 were selected. The two gene expression datasets GSE113342 (<xref ref-type="bibr" rid="B10">10</xref>) and GSE32591 (<xref ref-type="bibr" rid="B11">11</xref>) were downloaded. The GSE113342 dataset contained 14 LN glomerulus biopsy samples and six normal glomerulus biopsy samples. GSE32591 contained 32 LN glomerulus biopsy samples and 14 normal glomerulus biopsy samples.</p>
</sec>
<sec id="s4_2">
<title>Identification of Differentially Expressed Genes</title>
<p>The GEO2R online tool was used to identify DEGs between LN and normal glomerular biopsy samples. Log fold change (FC) &gt;1 and P-value &lt;0.01 were considered statistically significant. The raw data were checked online using Venn software to detect common DEGs. DEGs with log FC&#x2009;&lt;0 were considered downregulated, whereas DEGs with log FC&#x2009;&gt;0 were considered upregulated.</p>
</sec>
<sec id="s4_3">
<title>Functional Enrichment and Protein&#x2013;Protein Interaction Analysis</title>
<p>The Database for Annotation, Visualization, and Integrated Discovery (DAVID; <uri xlink:href="http://david.ncifcrf.gov">http://david.ncifcrf.gov</uri>) (<xref ref-type="bibr" rid="B12">12</xref>) is an online biological information database. The Kyoto Encyclopedia of Genes and Genomes (KEGG) is a database resource for understanding high-level functions and biological systems from large-scale molecular datasets generated using high-throughput experimental technologies (<xref ref-type="bibr" rid="B13">13</xref>). Gene Ontology (GO) is a major bioinformatics tool for annotating genes and analyzing their biological processes (<xref ref-type="bibr" rid="B14">14</xref>). DAVID 6.8 Bioinformatics Resources was used for pathway annotations. Statistical significance was set at P &lt; 0.05. A PPI network was established using the STRING (version 10.0) (<xref ref-type="bibr" rid="B15">15</xref>) online search tool, and an interaction with a combined score &gt;0.4 was considered statistically significant. The PPI network was visualized using Cytoscape (version 3.7.2).</p>
</sec>
<sec id="s4_4">
<title>Profiling Infiltrating Immune Cells With CIBERSORT in the Glomeruli</title>
<p>To assess the expression changes in immune cells and obtain the proportion of various types of immune cells from the glomerulus, we used the online CIBERSORT algorithm (<uri xlink:href="https://cibersort.stanford.edu/">https://cibersort.stanford.edu/</uri>). The GSE113342 and GSE32591 series matrix txt format files were downloaded from the NCBI GEO website, and the glomerular expression data were selected (GSM3103966, GSM3103968, GSM3103970, GSM3103972, GSM3103974, GSM3103976, GSM3103978, GSM3103980, GSM3103982, GSM3103984, GSM3103986, GSM3103988, GSM3103990, GSM3103992, GSM3103994-99, GSM807889-7934). Differences in 22 immune cells between normal and lupus glomeruli were analyzed.</p>
</sec>
<sec id="s4_5">
<title>Patients</title>
<p>All protocols were approved by the ethics committee of the Fujian Provincial Hospital. Overall, 30 LN patients with a mean age of 32.70 &#xb1; 12.17 years were included. Six types of pathological classifications (Classes II, III, IV, V, III+V, and IV+V) were used, with five patients in each pathological classification. Normal renal tissues from 5 patients with a mean age of 55.47 &#xb1; 8.82 years who underwent nephrectomy due to renal tumors were used as normal controls.</p>
</sec>
<sec id="s4_6">
<title>Immunofluorescence Staining of Glomerular S100A8</title>
<p>Renal biopsy specimens were embedded in an OCT mixture (Sakura, Hayward, CA, USA) and sliced into 5-&#x3bc;m frozen sections (<xref ref-type="bibr" rid="B16">16</xref>). The mouse anti-S100A8 antibody (Proteintech Group, Inc., Chicago, IL, USA) was used. Rabbit anti-synaptopodin antibody (Proteintech Group, Inc., Chicago, IL, USA) was used as a podocyte marker for double immunofluorescence staining. Goat anti-rabbit IgG/Alexa Fluor 594 antibody and goat anti-mouse IgG/Alexa Fluor 488 antibody (BIOGOT, Nanjing, China) were used to visualize the different proteins. 4',6-diamidino-2-phenylindole (DAPI) was used to stain the nucleus. Images were captured using a fluorescence microscope (Nikon Eclipse C1, Japan). Integral optical density (IOD) and the area ratio (AR) of the positively stained area to the glomerular area were used as semiquantitative values of the expression of S100A8. We used Image-Pro Plus software (<xref ref-type="bibr" rid="B17">17</xref>).</p>
</sec>
<sec id="s4_7">
<title>Correlation of Glomerular Expression of S100A8 With Clinical and Laboratory Data</title>
<p>The clinical data are from the cohort used for fluorescence staining of S100A8 in our study. Thirty LN patients were used for this correlation analysis. Six types of pathological classifications (Classes II, III, IV, V, III+V, and IV+V) were used, with five patients in each pathological classification.</p>
</sec>
<sec id="s4_8">
<title>Statistical Analysis</title>
<p>SPSS (version 21.0; SPSS Inc., Chicago, IL, USA) was used to compare the differences between the two groups using the <italic>t</italic>-test or Mann&#x2013;Whitney U test. The ratio was calculated using the &#x3c7;<sup>2</sup> test. Spearman correlation analysis was performed between clinical data and glomerular S100A8 expression levels. Statistical significance was set at P &lt; 0.05.</p>
</sec>
</sec>
<sec id="s5">
<title>Results</title>
<sec id="s5_1">
<title>Differentially Expressed Gene Identification</title>
<p>From the GSE113342 dataset, 93 DEGs were successfully identified, including 53 upregulated and 40 downregulated genes. From the GSE32591 dataset, 345 DEGs, involving 97 upregulated and 248 downregulated genes, were observed. Out of all the DEGs, 13 were common between the two datasets, as shown in the Venn diagram (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1A</bold></xref>). These 13 DEGs discovered between the LN glomerulus and the normal glomerulus based on the two microarray datasets consisted of 12 downregulated genes and one upregulated gene (S100A8). The 13 DEGs are plotted in <xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1B</bold></xref>, where the red and green dots represent upregulated and downregulated genes, respectively.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Identification of common DEGs from GSE32591 and GSE113342 datasets. <bold>(A)</bold> Venn diagram of DEGs based on the two GEO datasets. <bold>(B)</bold> Volcano plot of the 13 DEGs. Red, upregulation; green, downregulation. DEGs, differentially expressed genes; GEO, Gene Expression Omnibus.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-843576-g001.tif"/>
</fig>
</sec>
<sec id="s5_2">
<title>Gene Ontology Annotation and Kyoto Encyclopedia of Genes and Genomes Pathway Enrichment Analyses</title>
<p>To gain deeper insight into the biological roles of these 13 DEGs, functional and pathway enrichment analyses were performed using DAVID. The enriched GO terms and KEGG pathways are shown in <xref ref-type="table" rid="T1"><bold>Table&#xa0;1</bold></xref> and <xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2</bold></xref>. KEGG pathway analysis revealed that the DEGs were mainly associated with infections and the Toll-like receptor (TLR) signaling pathway. GO biological process analysis indicated that the 13 DEGs were significantly associated with inflammatory response, innate immune response, neutrophil chemotaxis, leukocyte migration, cell adhesion, and cell&#x2013;cell signaling. The top 3 significantly enriched terms regarding changes in cell component of DEGs were plasma membrane, extracellular exosome, and integral component of the plasma membrane. Changes in molecular function are primarily associated with protein binding.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>GO and KEGG pathway enrichment analysis of DEGs in LN glomerulus.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left"/>
<th valign="top" align="center">Term</th>
<th valign="top" align="center">Description</th>
<th valign="top" align="center">Count in gene set</th>
<th valign="top" align="center">P-value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" rowspan="7" align="left">KEGG_PATHWAY</td>
<td valign="top" align="left">hsa05133</td>
<td valign="top" align="left">Pertussis</td>
<td valign="top" align="center">5</td>
<td valign="top" align="center">4.06E-06</td>
</tr>
<tr>
<td valign="top" align="left">hsa05152</td>
<td valign="top" align="left">Tuberculosis</td>
<td valign="top" align="center">6</td>
<td valign="top" align="center">4.34E-06</td>
</tr>
<tr>
<td valign="top" align="left">hsa05150</td>
<td valign="top" align="left"><italic>Staphylococcus aureus</italic> infection</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">7.22E-05</td>
</tr>
<tr>
<td valign="top" align="left">hsa05134</td>
<td valign="top" align="left">Legionellosis</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">0.003179</td>
</tr>
<tr>
<td valign="top" align="left">hsa05140</td>
<td valign="top" align="left">Leishmaniasis</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">0.00544</td>
</tr>
<tr>
<td valign="top" align="left">hsa05142</td>
<td valign="top" align="left">Chagas disease (American trypanosomiasis)</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">0.011392</td>
</tr>
<tr>
<td valign="top" align="left">hsa04620</td>
<td valign="top" align="left">Toll-like receptor signaling pathway</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">0.011815</td>
</tr>
<tr>
<td valign="top" rowspan="25" align="left">Biological processes (BP)</td>
<td valign="top" align="left">GO:0006954</td>
<td valign="top" align="left">Inflammatory response</td>
<td valign="top" align="center">7</td>
<td valign="top" align="center">1.05E-07</td>
</tr>
<tr>
<td valign="top" align="left">GO:0045087</td>
<td valign="top" align="left">Innate immune response</td>
<td valign="top" align="center">7</td>
<td valign="top" align="center">2.21E-07</td>
</tr>
<tr>
<td valign="top" align="left">GO:0030593</td>
<td valign="top" align="left">Neutrophil chemotaxis</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">1.24E-05</td>
</tr>
<tr>
<td valign="top" align="left">GO:0050900</td>
<td valign="top" align="left">Leukocyte migration</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">7.85E-05</td>
</tr>
<tr>
<td valign="top" align="left">GO:0007155</td>
<td valign="top" align="left">Cell adhesion</td>
<td valign="top" align="center">5</td>
<td valign="top" align="center">2.29E-04</td>
</tr>
<tr>
<td valign="top" align="left">GO:0007267</td>
<td valign="top" align="left">Cell&#x2013;cell signaling</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">6.80E-04</td>
</tr>
<tr>
<td valign="top" align="left">GO:0007229</td>
<td valign="top" align="left">Integrin-mediated signaling pathway</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">0.002185</td>
</tr>
<tr>
<td valign="top" align="left">GO:0019221</td>
<td valign="top" align="left">Cytokine-mediated signaling pathway</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">0.003787</td>
</tr>
<tr>
<td valign="top" align="left">GO:0051092</td>
<td valign="top" align="left">Positive regulation of NF-kappaB transcription factor activity</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">0.003901</td>
</tr>
<tr>
<td valign="top" align="left">GO:0042742</td>
<td valign="top" align="left">Defense response to bacterium</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">0.004618</td>
</tr>
<tr>
<td valign="top" align="left">GO:0071404</td>
<td valign="top" align="left">Cellular response to low-density lipoprotein particle stimulus</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0.006415</td>
</tr>
<tr>
<td valign="top" align="left">GO:0070374</td>
<td valign="top" align="left">Positive regulation of ERK1 and ERK2 cascade</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">0.006655</td>
</tr>
<tr>
<td valign="top" align="left">GO:0002523</td>
<td valign="top" align="left">Leukocyte migration involved in the inflammatory response</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0.007835</td>
</tr>
<tr>
<td valign="top" align="left">GO:0016064</td>
<td valign="top" align="left">Immunoglobulin-mediated immune response</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0.007835</td>
</tr>
<tr>
<td valign="top" align="left">GO:0042535</td>
<td valign="top" align="left">Positive regulation of tumor necrosis factor biosynthetic process</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0.007835</td>
</tr>
<tr>
<td valign="top" align="left">GO:0030198</td>
<td valign="top" align="left">Extracellular matrix organization</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">0.008283</td>
</tr>
<tr>
<td valign="top" align="left">GO:0034142</td>
<td valign="top" align="left">Toll-like receptor 4 signaling pathway</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0.012792</td>
</tr>
<tr>
<td valign="top" align="left">GO:0051928</td>
<td valign="top" align="left">Positive regulation of calcium ion transport</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0.018429</td>
</tr>
<tr>
<td valign="top" align="left">GO:0002224</td>
<td valign="top" align="left">Toll-like receptor signaling pathway</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0.019131</td>
</tr>
<tr>
<td valign="top" align="left">GO:0002755</td>
<td valign="top" align="left">MyD88-dependent Toll-like receptor signaling pathway</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0.023337</td>
</tr>
<tr>
<td valign="top" align="left">GO:0031623</td>
<td valign="top" align="left">Receptor internalization</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0.03031</td>
</tr>
<tr>
<td valign="top" align="left">GO:0032755</td>
<td valign="top" align="left">Positive regulation of interleukin-6 production</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0.031699</td>
</tr>
<tr>
<td valign="top" align="left">GO:0032760</td>
<td valign="top" align="left">Positive regulation of tumor necrosis factor production</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0.033086</td>
</tr>
<tr>
<td valign="top" align="left">GO:0006955</td>
<td valign="top" align="left">Immune response</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">0.035053</td>
</tr>
<tr>
<td valign="top" align="left">GO:0070098</td>
<td valign="top" align="left">Chemokine-mediated signaling pathway</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0.049591</td>
</tr>
<tr>
<td valign="top" rowspan="7" align="left">Cell component (CC)</td>
<td valign="top" align="left">GO:0005886</td>
<td valign="top" align="left">Plasma membrane</td>
<td valign="top" align="center">10</td>
<td valign="top" align="center">1.71E-04</td>
</tr>
<tr>
<td valign="top" align="left">GO:0005602</td>
<td valign="top" align="left">Complement component C1 complex</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0.001317</td>
</tr>
<tr>
<td valign="top" align="left">GO:0009986</td>
<td valign="top" align="left">Cell surface</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">0.00471</td>
</tr>
<tr>
<td valign="top" align="left">GO:0005887</td>
<td valign="top" align="left">Integral component of plasma membrane</td>
<td valign="top" align="center">5</td>
<td valign="top" align="center">0.010799</td>
</tr>
<tr>
<td valign="top" align="left">GO:0008305</td>
<td valign="top" align="left">Integrin complex</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0.01764</td>
</tr>
<tr>
<td valign="top" align="left">GO:0070062</td>
<td valign="top" align="left">Extracellular exosome</td>
<td valign="top" align="center">6</td>
<td valign="top" align="center">0.026716</td>
</tr>
<tr>
<td valign="top" align="left">GO:0030670</td>
<td valign="top" align="left">Phagocytic vesicle membrane</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0.038177</td>
</tr>
<tr>
<td valign="top" rowspan="4" align="left">Molecular function (MF)</td>
<td valign="top" align="left">GO:0005515</td>
<td valign="top" align="left">Protein binding</td>
<td valign="top" align="center">13</td>
<td valign="top" align="center">3.93E-04</td>
</tr>
<tr>
<td valign="top" align="left">GO:0046982</td>
<td valign="top" align="left">Protein heterodimerization activity</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">0.003795</td>
</tr>
<tr>
<td valign="top" align="left">GO:0004872</td>
<td valign="top" align="left">Receptor activity</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">0.009973</td>
</tr>
<tr>
<td valign="top" align="left">GO:0001948</td>
<td valign="top" align="left">Glycoprotein binding</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0.045254</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; DEGs, differentially expressed genes; LN, lupus nephritis; ERK, extracellular regulated protein kinases.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Distribution of integrated DEGs in LN glomerulus for different enriched functions. The DEG enrichment of BP, MF, CC, and KEGG pathways (P&#x2009;&lt;&#x2009;0.05).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-843576-g002.tif"/>
</fig>
</sec>
<sec id="s5_3">
<title>Protein&#x2013;Protein Interaction and Modular Analysis</title>
<p>A total of 13 DEGs were imported into the PPI network complex, comprising 13 nodes and 57 edges, including 12 downregulated genes and the upregulated gene S100A8 (<xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3</bold></xref>). We then applied Cytotype MCODE for further analysis, and the results are shown in <xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3B</bold></xref>.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>PPI network and the significant module of DEGs. <bold>(A)</bold> The PPI network of DEGs. <bold>(B)</bold> The significant module was obtained from PPI network constructed using Cytoscape with 13 nodes and 57 edges. S100A8 is marked in yellow, and downregulated genes are marked in green.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-843576-g003.tif"/>
</fig>
</sec>
<sec id="s5_4">
<title>Infiltrating Immune Cells in the Glomeruli</title>
<p>We can conclude that monocytes (GSE32591) and eosinophils (GSE113342) accounted for the majority of all infiltrating cells in the glomerulus, especially in patients with LN. The differential expression proportion of immune-infiltrating cells in the LN and normal groups is shown in <xref ref-type="fig" rid="f4"><bold>Figures&#xa0;4</bold></xref>, <xref ref-type="fig" rid="f5"><bold>5</bold></xref>. Based on analyses of the GSE32591 database, we found that memory B cells, follicular helper T cells, regulatory T cells (Tregs), and resting natural killer (NK) cells were downregulated in LN glomeruli. In addition, monocytes and activated NK cells were upregulated. Analyses of the GSE113342 database revealed that naive B cells, plasma cells, and resting mast cells were downregulated, and monocytes and activated NK cells were upregulated, similar to the observations from GSE32591. In addition, activated mast cells and eosinophils were also upregulated.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>The differences of 22 immune cells between normal and lupus glomeruli. Monocytes and activated NK cells were upregulated in GSE32591 and GSE113342. *P &lt; 0.05; **P &lt; 0.01; ***P &lt; 0.001; ****P &lt; 0.0001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-843576-g004.tif"/>
</fig>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Stacked bar charts of 22 immune cell proportions in the glomeruli. In GSE32591, monocytes accounted for the majority of all infiltrating cells in the glomeruli. While in GSE113342, eosinophils are the majority.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-843576-g005.tif"/>
</fig>
</sec>
<sec id="s5_5">
<title>Clinical and Laboratory Information of the Lupus Nephritis Patients</title>
<p>No significant age- or sex-dependent differences were found among the renal biopsies of different LN groups. There were some differences in Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), Creatinine (Cr), Blood Urea  Nitrogen (BUN), C3, C4, and Albumin (Alb) among various ISN/RPS class LN patients. In patients with LN, no significant difference in 24-h urinary protein measurements was found. The details are presented in <xref ref-type="table" rid="T2"><bold>Table&#xa0;2</bold></xref>.</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Clinical and laboratory information of the LN patients.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Group</th>
<th valign="top" align="center">Control</th>
<th valign="top" align="center">LN patients</th>
<th valign="top" align="center">Class II</th>
<th valign="top" align="center">Class III</th>
<th valign="top" align="center">Class IV</th>
<th valign="top" align="center">Class V</th>
<th valign="top" align="center">Class III+V</th>
<th valign="top" align="center">Class IV+V</th>
<th valign="top" align="center">P-value (Control vs. LN)</th>
<th valign="top" align="center">P-value (Among LN)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Age (years)</td>
<td valign="top" align="char" char="&#xb1;">55.47 &#xb1; 8.82</td>
<td valign="top" align="char" char="&#xb1;">32.70 &#xb1; 12.17</td>
<td valign="top" align="char" char="&#xb1;">31.60 &#xb1; 11.89</td>
<td valign="top" align="char" char="&#xb1;">36.9 &#xb1; 17.61</td>
<td valign="top" align="char" char="&#xb1;">31.00 &#xb1; 12.75</td>
<td valign="top" align="char" char="&#xb1;">35.40 &#xb1; 11.15</td>
<td valign="top" align="char" char="&#xb1;">33.40 &#xb1; 12.08</td>
<td valign="top" align="char" char="&#xb1;">30.80 &#xb1; 11.97</td>
<td valign="top" align="center">&lt;0.01</td>
<td valign="top" align="center">0.05</td>
</tr>
<tr>
<td valign="top" align="left">Sex (F/M)</td>
<td valign="top" align="center">10/5</td>
<td valign="top" align="center">23/7</td>
<td valign="top" align="center">3/2</td>
<td valign="top" align="center">3/2</td>
<td valign="top" align="center">4/1</td>
<td valign="top" align="center">5/0</td>
<td valign="top" align="center">3/2</td>
<td valign="top" align="center">5/0</td>
<td valign="top" align="center">0.49</td>
<td valign="top" align="center">0.44</td>
</tr>
<tr>
<td valign="top" align="left">SLEDAI</td>
<td valign="top" align="center">NA</td>
<td valign="top" align="char" char="&#xb1;">18.57 &#xb1; 4.44</td>
<td valign="top" align="char" char="&#xb1;">14.40 &#xb1; 2.97</td>
<td valign="top" align="char" char="&#xb1;">15.8 &#xb1; 2.68</td>
<td valign="top" align="center">20.4 &#xb1; 2.97</td>
<td valign="top" align="center">17.2 &#xb1; 4.15</td>
<td valign="top" align="center">22.4 &#xb1; 3.36</td>
<td valign="top" align="char" char="&#xb1;">21.2 &#xb1; 5.02</td>
<td valign="top" align="center">NA</td>
<td valign="top" align="center">0.009</td>
</tr>
<tr>
<td valign="top" align="left">Cr (&#x3bc;mol/L)</td>
<td valign="top" align="char" char="&#xb1;">75.27 &#xb1; 21.30</td>
<td valign="top" align="char" char="&#xb1;">75.50 &#xb1; 72.43</td>
<td valign="top" align="char" char="&#xb1;">52.00 &#xb1; 10.89</td>
<td valign="top" align="char" char="&#xb1;">64.00 &#xb1; 10.08</td>
<td valign="top" align="char" char="&#xb1;">69.80 &#xb1; 10.46</td>
<td valign="top" align="center">134.20 &#xb1; 175.51</td>
<td valign="top" align="center">56.00 &#xb1; 14.25</td>
<td valign="top" align="char" char="&#xb1;">77.00 &#xb1; 31.96</td>
<td valign="top" align="center">0.99</td>
<td valign="top" align="center">0.04</td>
</tr>
<tr>
<td valign="top" align="left">BUN (mmol/L)</td>
<td valign="top" align="char" char="&#xb1;">4.89 &#xb1; 0.86</td>
<td valign="top" align="char" char="&#xb1;">7.00 &#xb1; 4.83</td>
<td valign="top" align="char" char="&#xb1;">5.38 &#xb1; 1.53</td>
<td valign="top" align="center">7.20 &#xb1; 1.60</td>
<td valign="top" align="center">4.92 &#xb1; 0.64</td>
<td valign="top" align="center">8.70 &#xb1; 8.47</td>
<td valign="top" align="center">3.88 &#xb1; 0.90</td>
<td valign="top" align="char" char="&#xb1;">11.90 &#xb1; 6.04</td>
<td valign="top" align="center">0.03</td>
<td valign="top" align="center">&lt;0.01</td>
</tr>
<tr>
<td valign="top" align="left">24-h UTP or Urine protein (g/24 h)</td>
<td valign="top" align="center">All negative</td>
<td valign="top" align="char" char="&#xb1;">1.66 &#xb1; 1.71</td>
<td valign="top" align="char" char="&#xb1;">0.95 &#xb1; 1.10</td>
<td valign="top" align="center">0.70 &#xb1; 0.47</td>
<td valign="top" align="center">1.53 &#xb1; 0.65</td>
<td valign="top" align="center">2.18 &#xb1; 1.57</td>
<td valign="top" align="center">2.16 &#xb1; 1.75</td>
<td valign="top" align="center">2.40 &#xb1; 3.25</td>
<td valign="top" align="center">&lt;0.01</td>
<td valign="top" align="center">0.54</td>
</tr>
<tr>
<td valign="top" align="left">C3 (g/L)</td>
<td valign="top" align="center">NA</td>
<td valign="top" align="char" char="&#xb1;">0.52 &#xb1; 0.09</td>
<td valign="top" align="center">0.53 &#xb1; 0.24</td>
<td valign="top" align="char" char="&#xb1;">0.68 &#xb1; 0.37</td>
<td valign="top" align="center">0.29 &#xb1; 0.14</td>
<td valign="top" align="center">0.89 &#xb1; 0.35</td>
<td valign="top" align="center">0.36 &#xb1; 0.16</td>
<td valign="top" align="center">0.37 &#xb1; 0.09</td>
<td valign="top" align="center">NA</td>
<td valign="top" align="center">0.007</td>
</tr>
<tr>
<td valign="top" align="left">C4 (g/L)</td>
<td valign="top" align="center">NA</td>
<td valign="top" align="char" char="&#xb1;">0.09 &#xb1; 0.07</td>
<td valign="top" align="center">0.08 &#xb1; 0.04</td>
<td valign="top" align="char" char="&#xb1;">0.11 &#xb1; 0.08</td>
<td valign="top" align="center">0.07 &#xb1; 0.05</td>
<td valign="top" align="center">0.18 &#xb1; 0.13</td>
<td valign="top" align="center">0.05 &#xb1; 0.03</td>
<td valign="top" align="center">0.06 &#xb1; 0.03</td>
<td valign="top" align="center">NA</td>
<td valign="top" align="center">0.06</td>
</tr>
<tr>
<td valign="top" align="left">Alb (g/L)</td>
<td valign="top" align="center">NA</td>
<td valign="top" align="char" char="&#xb1;">32.33 &#xb1; 6.58</td>
<td valign="top" align="char" char="&#xb1;">38.20 &#xb1; 4.15</td>
<td valign="top" align="char" char="&#xb1;">33.20 &#xb1; 7.40</td>
<td valign="top" align="char" char="&#xb1;">26.60 &#xb1; 7.40</td>
<td valign="top" align="char" char="&#xb1;">35.80 &#xb1; 3.70</td>
<td valign="top" align="char" char="&#xb1;">31.60 &#xb1; 2.61</td>
<td valign="top" align="char" char="&#xb1;">28.60 &#xb1; 6.95</td>
<td valign="top" align="center">NA</td>
<td valign="top" align="center">0.04</td>
</tr>
<tr>
<td valign="top" align="left">Glomerular S100A8-AR</td>
<td valign="top" align="center">0.002 (0.001, 0.005)</td>
<td valign="top" align="center">0.010 (0.002, 0.028)</td>
<td valign="top" align="center">0.002 (0.001, 0.005)</td>
<td valign="top" align="center">0.026 (0.020, 0.075)</td>
<td valign="top" align="center">0.059 (0.035, 0.107)</td>
<td valign="top" align="center">0.003 (0.000, 0.003)</td>
<td valign="top" align="center">0.013 (0.006, 0.033)</td>
<td valign="top" align="center">0.018 (0.008, 0.034)</td>
<td valign="top" align="center">0.002</td>
<td valign="top" align="center">&lt;0.01</td>
</tr>
<tr>
<td valign="top" align="left">Glomerular S100A8-IOD</td>
<td valign="top" align="center">5.967 (2.149, 16.933)</td>
<td valign="top" align="center">24.805 (5.647, 87.4068)</td>
<td valign="top" align="center">6.982 (2.161, 13.752)</td>
<td valign="top" align="center">82.603 (20.480, 147.444)</td>
<td valign="top" align="center">227.417 (133.910, 407.012)</td>
<td valign="top" align="center">1.027 (0.000, 10.880)</td>
<td valign="top" align="center">39.839 (14.546, 90.071)</td>
<td valign="top" align="center">62.562 (20.069, 100.833)</td>
<td valign="top" align="center">0.006</td>
<td valign="top" align="center">&lt;0.01</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s5_6">
<title>Glomerular Expression of S100A8 in Various ISN/RPS Class Lupus Nephritis Patients</title>
<p>Using immunofluorescence microscopy, the glomerular staining of S100A8 in the controls was found to be weak, and the staining in patients with classes II and V was similar to that of the controls. Glomerular staining was markedly enhanced in Class IV. We found the S100A8 proteins to be distributed throughout the glomerulus, and S100A8 did not colocalize with the podocyte marker synaptopodin (<xref ref-type="fig" rid="f6"><bold>Figure&#xa0;6</bold></xref>).</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Glomerular expression of S100A8 in various ISN/RPS class LN patients.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-843576-g006.tif"/>
</fig>
<p>We conducted a semiquantitative analysis and found a significant increase in IOD and AR in LN compared with that of the controls. However, no significant differences were found in the glomerular expression of S100A8 between the control and class II groups or control and class V groups (<xref ref-type="table" rid="T2"><bold>Tables&#xa0;2</bold></xref>, <xref ref-type="table" rid="T3"><bold>3</bold></xref>).</p>
<table-wrap id="T3" position="float">
<label>Table&#xa0;3</label>
<caption>
<p>Glomerular expression of S100A8 in various ISN/RPS class LN patients.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Glomerular S100A8-AR/IOD</th>
<th valign="top" rowspan="2" align="center">Control</th>
<th valign="top" rowspan="2" align="center">LN patients</th>
<th valign="top" rowspan="2" align="center">Class II</th>
<th valign="top" rowspan="2" align="center">Class III</th>
<th valign="top" rowspan="2" align="center">Class IV</th>
<th valign="top" rowspan="2" align="center">Class V</th>
<th valign="top" rowspan="2" align="center">Class III+V</th>
<th valign="top" rowspan="2" align="center">Class IV+V</th>
</tr>
<tr>
<th valign="top" align="left">P value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Control</td>
<td valign="top" align="center">0.002 (0.001, 0.005)/5.967 (2.149, 16.933)</td>
<td valign="top" align="center">0.002/0.006</td>
<td valign="top" align="center">0.955/0.966</td>
<td valign="top" align="center">&lt;0.001/0.001</td>
<td valign="top" align="center">&lt;0.001/&lt;0.001</td>
<td valign="top" align="center">0.856/0.916</td>
<td valign="top" align="center">0.002/0.013</td>
<td valign="top" align="center">&lt;0.001/&lt;0.001</td>
</tr>
<tr>
<td valign="top" align="left">LN patients</td>
<td valign="top" align="center">0.002/0.006</td>
<td valign="top" align="center">0.010 (0.002, 0.028)/24.805 (5.647, 87.4068)</td>
<td valign="top" align="center">&lt;0.001/&lt;0.001</td>
<td valign="top" align="center">0.003/0.387</td>
<td valign="top" align="center">&lt;0.001/&lt;0.001</td>
<td valign="top" align="center">0.001/0.005</td>
<td valign="top" align="center">0.988/0.693</td>
<td valign="top" align="center">0.601/0.312</td>
</tr>
<tr>
<td valign="top" align="left">Class II</td>
<td valign="top" align="center">0.955/0.966</td>
<td valign="top" align="center">&lt;0.001/&lt;0.001</td>
<td valign="top" align="center">0.002 (0.001, 0.005)/6.982 (2.161, 13.752)</td>
<td valign="top" align="center">&lt;0.001/0.001</td>
<td valign="top" align="center">&lt;0.001/&lt;0.001</td>
<td valign="top" align="center">0.814/0.884</td>
<td valign="top" align="center">&lt;0.001/0.015</td>
<td valign="top" align="center">&lt;0.001/&lt;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Class III</td>
<td valign="top" align="center">&lt;0.001/0.001</td>
<td valign="top" align="center">0.003/0.387</td>
<td valign="top" align="center">&lt;0.001/0.001</td>
<td valign="top" align="center">0.026 (0.020, 0.075)/82.603 (20.480, 147.444)</td>
<td valign="top" align="center">&lt;0.001/&lt;0.001</td>
<td valign="top" align="center">&lt;0.001/0.001</td>
<td valign="top" align="center">&lt;0.001/0.218</td>
<td valign="top" align="center">&lt;0.001/0.887</td>
</tr>
<tr>
<td valign="top" align="left">Class IV</td>
<td valign="top" align="center">&lt;0.001/&lt;0.001</td>
<td valign="top" align="center">&lt;0.001/&lt;0.001</td>
<td valign="top" align="center">&lt;0.001/&lt;0.001</td>
<td valign="top" align="center">&lt;0.001/&lt;0.001</td>
<td valign="top" align="center">0.059 (0.035, 0.107)/227.417 (133.910, 407.012)</td>
<td valign="top" align="center">&lt;0.001/&lt;0.001</td>
<td valign="top" align="center">&lt;0.001/&lt;0.001</td>
<td valign="top" align="center">&lt;0.001/&lt;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Class V</td>
<td valign="top" align="center">0.856/0.916</td>
<td valign="top" align="center">0.001/0.005</td>
<td valign="top" align="center">0.814/0.884</td>
<td valign="top" align="center">&lt;0.001/0.001</td>
<td valign="top" align="center">&lt;0.001/&lt;0.001</td>
<td valign="top" align="center">0.003 (0.000, 0.003)/1.027 (0.000, 10.880)</td>
<td valign="top" align="center">&lt;0.001/0.016</td>
<td valign="top" align="center">&lt;0.001/&lt;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Class III+V</td>
<td valign="top" align="center">0.002/0.013</td>
<td valign="top" align="center">0.988/0.693</td>
<td valign="top" align="center">&lt;0.001/0.015</td>
<td valign="top" align="center">&lt;0.001/0.218</td>
<td valign="top" align="center">&lt;0.001/&lt;0.001</td>
<td valign="top" align="center">&lt;0.001/0.016</td>
<td valign="top" align="center">0.013 (0.006, 0.033)/39.839 (14.546, 90.071)</td>
<td valign="top" align="center">0.632/0.208</td>
</tr>
<tr>
<td valign="top" align="left">Class IV+V</td>
<td valign="top" align="center">&lt;0.001/&lt;0.001</td>
<td valign="top" align="center">0.601/0.312</td>
<td valign="top" align="center">&lt;0.001/&lt;0.001</td>
<td valign="top" align="center">&lt;0.001/0.887</td>
<td valign="top" align="center">&lt;0.001/&lt;0.001</td>
<td valign="top" align="center">&lt;0.001/&lt;0.001</td>
<td valign="top" align="center">0.632/0.208</td>
<td valign="top" align="center">0.018 (0.008, 0.034)/62.562 (20.069, 100.833)</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s5_7">
<title>Correlation of Glomerular Expression of S100A8 With Clinical and Laboratory Data</title>
<p>The IOD of S100A8 positively correlated with the AR of S100A8. However, the IOD and AR of S100A8 did not correlate with clinical and laboratory data. Correlations were observed among anti-ds DNA, SLEDAI, Cr, BUN, C3, C4, Alb, and 24-h urinary total protein (UTP) in various ISN/RPS class LN patients. The details are presented in <xref ref-type="fig" rid="f7"><bold>Figure&#xa0;7</bold></xref>.</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>The correlation of glomerular expression of S100A8 with clinical and laboratory data. *P &lt; 0.05; **P &lt; 0.01;***P &lt; 0.001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-843576-g007.tif"/>
</fig>
</sec>
</sec>
<sec id="s6" sec-type="discussion">
<title>Discussion</title>
<p>In this study, we used bioinformatics analysis to identify 13 DEGs (CYBB, C1QA, C1QB, ITGB2, ITGAM, IL10RA, TLR1, MYD88, CCL4, CD44, CCR1, FCER1G, and S100A8) that were common between LN and normal glomeruli based on gene expression profiles obtained from the GSE113342 and GSE32591 datasets.</p>
<p>Proteins expressed by these genes are distributed in a variety of inflammatory cells. They are also chemokine receptors for inflammatory cells (<xref ref-type="bibr" rid="B18">18</xref>&#x2013;<xref ref-type="bibr" rid="B28">28</xref>). Through enrichment analysis, we found that these genes were mainly related to the inflammatory response, innate immune response, neutrophil chemotaxis, leukocyte migration, cell adhesion, and cell&#x2013;cell signaling. These factors are closely related to the pathogenesis of LN.</p>
<p>We also observed differential expression of immune cells, including T cells, B cells, NK cells, and macrophages, in the LN and normal groups. Studies have reported that humoral and cellular immunity is involved in the pathogenesis of LN (<xref ref-type="bibr" rid="B29">29</xref>). A variety of autoantibodies that form immune complexes are deposited in the glomerulus, causing kidney tissue damage (<xref ref-type="bibr" rid="B30">30</xref>). Various immune cells can infiltrate kidney tissues. B-cell infiltration can produce many antibodies, causing kidney tissue damage and aggravating local inflammation. Activated T cells infiltrate kidney tissue and secrete cytokines, causing kidney damage. Macrophages activate a variety of signaling pathways and promote inflammation (<xref ref-type="bibr" rid="B31">31</xref>). They can cause glomerular mesangial matrix proliferation, innate cells, and damage to the structure or function of the kidney tissue (<xref ref-type="bibr" rid="B32">32</xref>). Macrophages can also release a large number of chemical and inflammatory mediators that aggravate kidney damage (<xref ref-type="bibr" rid="B33">33</xref>).</p>
<p>In this study, we found that S100A8 was differentially regulated in the above two microarray datasets between LN and normal glomeruli. Using immunofluorescence staining, we found that S100A8 levels in the controls were weak. Glomerular staining was markedly enhanced compared to that in the controls, especially in class IV. Protein S100A8 belongs to the calcium-binding S100 protein family and has gained considerable interest as a critical modulator of inflammatory response after its cellular release (<xref ref-type="bibr" rid="B34">34</xref>). Basic and clinical studies have suggested a potential link between S100A8 and LN (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>). Consistent with our research, Frosch et&#xa0;al. (<xref ref-type="bibr" rid="B35">35</xref>) reported that the expression pattern of S100A8 markedly differed between the glomeruli and interstitium in LN. S100A8 expression was significantly increased in the interstitium, paralleling the findings in glomeruli. Intrarenal S100A8 expression is increased in refractory patients with ISN/RPS class III/IV LN (<xref ref-type="bibr" rid="B36">36</xref>). Davies et&#xa0;al. (<xref ref-type="bibr" rid="B37">37</xref>) found that serum and urine S100A8 levels were elevated in patients with SLE, and the urine/serum ratios were elevated in patients with active LN. Tantivitayakul et&#xa0;al. (<xref ref-type="bibr" rid="B38">38</xref>) detected S100A8 in infiltrating cells of glomeruli and peritubular capillaries.</p>
<p>Macrophage infiltration is associated with the severity of the inflammatory response, and macrophages express a large amount of S100A8, which participates in the pathogenesis of LN. Staining of S100A8 in patients with classes II and V was similar to that of the controls and was enhanced in classes III, IV, III+V, and IV+V. Therefore, we speculate that the pathogenesis of S100A8 varies in different pathological types. Unfortunately, we did not find a relationship between S100A8 levels and clinical or laboratory data. However, the exact mechanisms of pathogenesis remain unclear. Further research is required to confirm the role of S100A8 in LN. One study reported that S100A8 could be a promising therapeutic target for myocardial ischemia&#x2013;reperfusion injury (<xref ref-type="bibr" rid="B39">39</xref>). This is an important question that needs to be explored in future research.</p>
</sec>
<sec id="s7" sec-type="conclusions">
<title>Conclusions</title>
<p>We used bioinformatics to determine the DEGs between the LN glomerulus and normal glomerulus. Immunofluorescence staining was used to identify the expression level of S100A8 in various ISN/RPS classes of LN. We found that the number of monocytes and activated NK cells were upregulated in the LN glomeruli, and the glomerular S100A8 level differed in different pathological types. Glomerular S100A8 staining was markedly increased in LN glomeruli compared to that in the controls, especially in class IV. Our results indicate that S100A8 participates in the pathogenesis of LN, and the precise mechanisms of this process need to be explored in our follow-up research.</p>
</sec>
<sec id="s8" sec-type="data-availability">
<title>Data Availability Statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Material</bold></xref>.</p>
</sec>
<sec id="s9" sec-type="ethics-statement">
<title>Ethics Statement</title>
<p>The studies involving human participants were reviewed and approved by the ethics committee of Fujian Provincial Hospital. The patients/participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="s10" sec-type="author-contributions">
<title>Author Contributions</title>
<p>WQ collected and analyzed clinical data and drafted the article. PM did immunofluorescence staining. YQ and GF helped WQ to collect and interpret data for the work. CZ and WZ designed this topic and approved the final version of manuscript. LH revised the manuscript carefully.</p>
</sec>
<sec id="s11" sec-type="funding-information">
<title>Funding</title>
<p>This work was supported by Natural Science Foundation of Fujian province (Grant No.2019J01184, 2021J05065) and joint funds for the innovation of science and technology of Fujian province (Grant No.2020Y9027).</p>
</sec>
<sec id="s12" sec-type="COI-statement">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s13" sec-type="disclaimer">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<sec id="s14" sec-type="supplementary-material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2022.843576/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fimmu.2022.843576/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet_1.zip" id="SM1" mimetype="application/zip"/>
<supplementary-material xlink:href="DataSheet_2.zip" id="SM2" mimetype="application/zip"/>
<supplementary-material xlink:href="DataSheet_3.pdf" id="SM3" mimetype="application/pdf"/>
<supplementary-material xlink:href="Image_1.jpeg" id="SF1" mimetype="image/jpeg"/>
<supplementary-material xlink:href="Image_2.jpeg" id="SF2" mimetype="image/jpeg"/>
<supplementary-material xlink:href="Image_3.jpeg" id="SF3" mimetype="image/jpeg"/>
<supplementary-material xlink:href="Image_4.jpeg" id="SF4" mimetype="image/jpeg"/>
<supplementary-material xlink:href="Image_5.jpeg" id="SF5" mimetype="image/jpeg"/>
<supplementary-material xlink:href="Image_6.jpeg" id="SF6" mimetype="image/jpeg"/>
<supplementary-material xlink:href="Image_7.jpeg" id="SF7" mimetype="image/jpeg"/>
<supplementary-material xlink:href="Image_8.jpeg" id="SF8" mimetype="image/jpeg"/>
<supplementary-material xlink:href="Image_9.jpeg" id="SF9" mimetype="image/jpeg"/>
<supplementary-material xlink:href="Image_10.jpeg" id="SF10" mimetype="image/jpeg"/>
<supplementary-material xlink:href="Image_11.jpeg" id="SF11" mimetype="image/jpeg"/>
<supplementary-material xlink:href="Image_12.jpeg" id="SF12" mimetype="image/jpeg"/>
<supplementary-material xlink:href="Image_13.jpeg" id="SF13" mimetype="image/jpeg"/>
<supplementary-material xlink:href="Image_14.jpeg" id="SF14" mimetype="image/jpeg"/>
<supplementary-material xlink:href="Image_15.jpeg" id="SF15" mimetype="image/jpeg"/>
<supplementary-material xlink:href="Table_1.docx" id="ST1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
<supplementary-material xlink:href="Table_2.docx" id="ST2" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
<supplementary-material xlink:href="Table_3.docx" id="ST3" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Almaani</surname> <given-names>S</given-names>
</name>
<name>
<surname>Meara</surname> <given-names>A</given-names>
</name>
<name>
<surname>Rovin</surname> <given-names>BH</given-names>
</name>
</person-group>. <article-title>Update on Lupus Nephritis</article-title>. <source>Clin J Am Soc Nephrol</source> (<year>2017</year>) <volume>12</volume>(<issue>5</issue>):<page-range>825&#x2013;35</page-range>. doi: <pub-id pub-id-type="doi">10.2215/CJN.05780616</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>F</given-names>
</name>
<name>
<surname>Song</surname> <given-names>D</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>SX</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>MH</given-names>
</name>
</person-group>. <article-title>Podocyte Involvement in Lupus Nephritis Based on the 2003 ISN/RPS System: A Large Cohort Study From a Single Center</article-title>. <source>Rheumatology</source> (<year>2014</year>) <volume>53</volume>:<page-range>1235&#x2013;44</page-range>. doi: <pub-id pub-id-type="doi">10.1093/rheumatology/ket491</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yung</surname> <given-names>S</given-names>
</name>
<name>
<surname>Yap</surname> <given-names>DY</given-names>
</name>
<name>
<surname>Chan</surname> <given-names>TM</given-names>
</name>
</person-group>. <article-title>A Review of Advances in the Understanding of Lupus Nephritis Pathogenesis as a Basis for Emerging Therapies</article-title>. <source>F1000Res</source> (<year>2020</year>) <volume>9</volume>:<page-range>F1000 Faculty Rev&#x2013;905</page-range>. doi: <pub-id pub-id-type="doi">10.12688/f1000research.22438.1</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Song</surname> <given-names>R</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Jing</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>S100A8/A9 in Inflammation</article-title>. <source>Front Immunol</source> (<year>2018</year>) <volume>9</volume>:<elocation-id>1298</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2018.01298</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pruenster</surname> <given-names>M</given-names>
</name>
<name>
<surname>Vogl</surname> <given-names>T</given-names>
</name>
<name>
<surname>Roth</surname> <given-names>J</given-names>
</name>
<name>
<surname>Sperandio</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>S100A8/A9: From Basic Science to Clinical Application</article-title>. <source>Pharmacol Ther</source> (<year>2016</year>) <volume>167</volume>:<page-range>120&#x2013;31</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.pharmthera.2016.07.015</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liya</surname> <given-names>L</given-names>
</name>
<name>
<surname>Xiaoxia</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Yizhi</surname> <given-names>X</given-names>
</name>
<name>
<surname>Di</surname> <given-names>L</given-names>
</name>
<name>
<surname>Hui</surname> <given-names>L</given-names>
</name>
<name>
<surname>Honglin</surname> <given-names>Z</given-names>
</name>
</person-group>. <article-title>Neutrophil-Derived Exosome From Systemic Sclerosis Inhibits the Proliferation and Migration of Endothelial Cells</article-title>. <source>Biochem Biophys Res Commun</source> (<year>2020</year>) <volume>526</volume>(<issue>2</issue>):<page-range>334&#x2013;40</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.bbrc.2020.03.088</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Donohue</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Midgley</surname> <given-names>A</given-names>
</name>
<name>
<surname>Davies</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Wright</surname> <given-names>RD</given-names>
</name>
<name>
<surname>Bruce</surname> <given-names>I</given-names>
</name>
<name>
<surname>Beresford</surname> <given-names>MW</given-names>
</name>
<etal/>
</person-group>. <article-title>Differential Analysis of Serum and Urine S100 Proteins in Juvenile-Onset Systemic Lupus Erythematosus (jSLE)</article-title>. <source>Clin Immunol</source> (<year>2020</year>) <volume>214</volume>:<fpage>108375</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.clim.2020.108375</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turnier</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Fall</surname> <given-names>N</given-names>
</name>
<name>
<surname>Thornton</surname> <given-names>S</given-names>
</name>
<name>
<surname>Witte</surname> <given-names>D</given-names>
</name>
<name>
<surname>Bennett</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Appenzeller</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Urine S100 Proteins as Potential Biomarkers of Lupus Nephritis Activity</article-title>. <source>Arthritis Res Ther</source> (<year>2017</year>) <volume>19</volume>(<issue>1</issue>):<fpage>242</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13075-017-1444-4</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barrett</surname> <given-names>T</given-names>
</name>
<name>
<surname>Troup</surname> <given-names>DB</given-names>
</name>
<name>
<surname>Wilhite</surname> <given-names>SE</given-names>
</name>
<name>
<surname>Ledoux</surname> <given-names>P</given-names>
</name>
<name>
<surname>Rudnev</surname> <given-names>D</given-names>
</name>
<name>
<surname>Evangelista</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>NCBI GEO: Mining Tens of Millions of Expression Profiles&#x2013;Database and Tools Update</article-title>. <source>Nucleic Acids Res</source> (<year>2007</year>) <volume>35</volume>(<issue>Database issue</issue>):<page-range>D760&#x2013;5</page-range>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkl887</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="web">Available at: <uri xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE113342">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE113342</uri>.</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="web">Available at: <uri xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE32591">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE32591</uri>.</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dennis</surname> <given-names>G</given-names> <suffix>Jr</suffix>
</name>
<name>
<surname>Sherman</surname> <given-names>BT</given-names>
</name>
<name>
<surname>Hosack</surname> <given-names>DA</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>W</given-names>
</name>
<name>
<surname>Lane</surname> <given-names>HC</given-names>
</name>
<etal/>
</person-group>. <article-title>DAVID: Database for Annotation, Visualization, and Integrated Discovery</article-title>. <source>Genome Biol</source> (<year>2003</year>) <volume>4</volume>(<issue>5</issue>):<fpage>P3</fpage>. doi: <pub-id pub-id-type="doi">10.1186/gb-2003-4-5-p3</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ogata</surname> <given-names>H</given-names>
</name>
<name>
<surname>Goto</surname> <given-names>S</given-names>
</name>
<name>
<surname>Sato</surname> <given-names>K</given-names>
</name>
<name>
<surname>Fujibuchi</surname> <given-names>W</given-names>
</name>
<name>
<surname>Bono</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kanehisa</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>KEGG: Kyoto Encyclopedia of Genes and Genomes</article-title>. <source>Nucleic Acids Res</source> (<year>1999</year>) <volume>27</volume>(<issue>1</issue>):<fpage>29</fpage>&#x2013;<lpage>34</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/27.1.29</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="web">Available at: <uri xlink:href="http://geneontology.org/page/download-ontology">http://geneontology.org/page/download-ontology</uri>.</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="web">Available at: <uri xlink:href="http://string-db.org">http://string-db.org</uri>.</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>QiJiao</surname> <given-names>W</given-names>
</name>
<name>
<surname>Han</surname> <given-names>X</given-names>
</name>
<name>
<surname>Na</surname> <given-names>G</given-names>
</name>
<name>
<surname>Yali</surname> <given-names>R</given-names>
</name>
<name>
<surname>Xiaoya</surname> <given-names>L</given-names>
</name>
<name>
<surname>Guohong</surname> <given-names>W</given-names>
</name>
<etal/>
</person-group>. <article-title>Overproduction of Mitochondrial Fission Proteins in Membranous Nephropathy in Children</article-title>. <source>Kidney Blood Press Res</source> (<year>2018</year>) <volume>43</volume>:<page-range>1927&#x2013;34</page-range>. doi: <pub-id pub-id-type="doi">10.1159/000496006</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>QiJiao</surname> <given-names>W</given-names>
</name>
<name>
<surname>Xiaoya</surname> <given-names>L</given-names>
</name>
<name>
<surname>Guohong</surname> <given-names>W</given-names>
</name>
<name>
<surname>Hairong</surname> <given-names>W</given-names>
</name>
<name>
<surname>Sainan</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Na</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Mitochondrial Fission Proteins Are Involved in Proteinuria in Adriamycin-Induced Rat Nephropathy</article-title>. <source>J Nephrol Dialy Transplant</source> (<year>2017</year>) <volume>26</volume>(<issue>1</issue>):<fpage>37</fpage>&#x2013;<lpage>43</lpage>. doi: <pub-id pub-id-type="doi">10.3969/cndt.j.issn.1006&#x2014;298X.2017.01.007</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klocke</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kopetschke</surname> <given-names>K</given-names>
</name>
<name>
<surname>Grie&#xdf;bach</surname> <given-names>AS</given-names>
</name>
<name>
<surname>Langhans</surname> <given-names>V</given-names>
</name>
<name>
<surname>Humrich</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Biesen</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Mapping Urinary Chemokines in Human Lupus Nephritis: Potentially Redundant Pathways Recruit CD4+ and CD8+ T Cells and Macrophages</article-title>. <source>Eur J Immunol</source> (<year>2017</year>) <volume>47</volume>(<issue>1</issue>):<page-range>180&#x2013;92</page-range>. doi: <pub-id pub-id-type="doi">10.1002/eji.201646387</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yung</surname> <given-names>S</given-names>
</name>
<name>
<surname>Chan</surname> <given-names>TM</given-names>
</name>
</person-group>. <article-title>The Role of Hyaluronan and CD44 in the Pathogenesis of Lupus Nephritis</article-title>. <source>Autoimmune Dis</source> (<year>2012</year>) <volume>2012</volume>:<fpage>207190</fpage>. doi: <pub-id pub-id-type="doi">10.1155/2012/207190</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Lian</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>B</given-names>
</name>
<name>
<surname>Liz</surname>
</name>
<name>
<surname>Zen</surname> <given-names>GL</given-names>
</name>
<name>
<surname>Li</surname> <given-names>W</given-names>
</name>
<etal/>
</person-group>. <article-title>Effect of Ligustrazine Nanoparticles on Th1/Th2 Balance by TLR4/MyD88/NF-&#x3ba;b Pathway in Rats With Postoperative Peritoneal Adhesion</article-title>. <source>BMC Surg</source> (<year>2021</year>) <volume>21</volume>(<issue>1</issue>):<fpage>211</fpage>. doi: <pub-id pub-id-type="doi">10.1159/000496006</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname> <given-names>XJ</given-names>
</name>
<name>
<surname>Klionsky</surname> <given-names>DJ</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Podocytes and Autophagy: A Potential Therapeutic Target in Lupus Nephritis</article-title>. <source>Autophagy</source> (<year>2019</year>) <volume>15</volume>(<issue>5</issue>):<page-range>908&#x2013;12</page-range>. doi: <pub-id pub-id-type="doi">10.1080/15548627.2019.1580512</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>YH</given-names>
</name>
<name>
<surname>Bae</surname> <given-names>SC</given-names>
</name>
</person-group>. <article-title>Association Between the Functional ITGAM Rs1143679 G/A Polymorphism and Systemic Lupus Erythematosus/Lupus Nephritis or Rheumatoid Arthritis: An Update Meta-Analysis</article-title>. <source>Rheumatol Int</source> (<year>2015</year>) <volume>35</volume>(<issue>5</issue>):<page-range>815&#x2013;23</page-range>. doi: <pub-id pub-id-type="doi">10.1007/s00296-014-3156-2</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghafouri-Fard</surname> <given-names>S</given-names>
</name>
<name>
<surname>Shahir</surname> <given-names>M</given-names>
</name>
<name>
<surname>Taheri</surname> <given-names>M</given-names>
</name>
<name>
<surname>Salimi</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>A Review on the Role of Chemokines in the Pathogenesis of Systemic Lupus Erythematosus</article-title>. <source>Cytokine</source> (<year>2021</year>) <volume>146</volume>:<fpage>155640</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cyto.2021.155640</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yavuz</surname> <given-names>S</given-names>
</name>
<name>
<surname>Bianchi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kozyrev</surname> <given-names>S</given-names>
</name>
<name>
<surname>Bolin</surname> <given-names>K</given-names>
</name>
<name>
<surname>Leonard</surname> <given-names>D</given-names>
</name>
<name>
<surname>Pucholt</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Toll-Like Receptors Revisited; a Possible Role for TLR1 in Lupus Nephritis</article-title>. <source>Ann Rheum Dis</source> (<year>2020</year>) <volume>80</volume>(<issue>3</issue>):<page-range>404&#x2013;6</page-range>. doi: <pub-id pub-id-type="doi">10.1136/annrheumdis-2020-218373</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Lan</surname> <given-names>R</given-names>
</name>
<name>
<surname>Ye</surname> <given-names>K</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>H</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>C</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Prioritization of Diagnostic and Prognostic Biomarkers for Lupus Nephritis Based on Integrated Bioinformatics Analyses</article-title>. <source>Front Bioeng Biotechnol</source> (<year>2021</year>) <volume>9</volume>:<elocation-id>717234</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fbioe.2021.717234</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>T</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>M</given-names>
</name>
<name>
<surname>Xia</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Li</surname> <given-names>C</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Microarray-Based Analysis of Renal Complement Components Reveals a Therapeutic Target for Lupus Nephritis</article-title>. <source>Arthritis Res Ther</source> (<year>2021</year>) <volume>23</volume>(<issue>1</issue>):<fpage>223</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13075-021-02605-9</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liao</surname> <given-names>DJ</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>XP</given-names>
</name>
<name>
<surname>Li</surname> <given-names>N</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>KL</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>SY</given-names>
</name>
<etal/>
</person-group>. <article-title>A Comparative Study on the Incidence, Aggravation, and Remission of Lupus Nephritis Based on iTRAQ Technology</article-title>. <source>Comb Chem High Throughput Screen</source> (<year>2020</year>) <volume>23</volume>(<issue>7</issue>):<page-range>649&#x2013;57</page-range>. doi: <pub-id pub-id-type="doi">10.2174/1386207323666200416151836</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>W</given-names>
</name>
</person-group>. <article-title>Immune Cell Infiltration Characteristics and Related Core Genes in Lupus Nephritis: Results From Bioinformatic Analysis</article-title>. <source>BMC Immunol</source> (<year>2019</year>) <volume>20</volume>(<issue>1</issue>):<fpage>37</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12865-019-0316-x</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname> <given-names>A</given-names>
</name>
<name>
<surname>Clark</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Ko</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Cellular Aspects of the Pathogenesis of Lupus Nephritis</article-title>. <source>Curr Opin Rheumatol</source> (<year>2021</year>) <volume>33</volume>(<issue>2</issue>):<fpage>197</fpage>&#x2013;<lpage>204</lpage>. doi: <pub-id pub-id-type="doi">10.1097/BOR.0000000000000777</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Onishi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Adnan</surname> <given-names>E</given-names>
</name>
<name>
<surname>Ishizaki</surname> <given-names>J</given-names>
</name>
<name>
<surname>Miyazaki</surname> <given-names>T</given-names>
</name>
<name>
<surname>Tanaka</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Matsumoto</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Novel Autoantigens Associated With Lupus Nephritis</article-title>. <source>PloS One</source> (<year>2015</year>) <volume>10</volume>(<issue>6</issue>):<elocation-id>e0126564</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0126564</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuroiwa</surname> <given-names>T</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>EG</given-names>
</name>
</person-group>. <article-title>Cellular Interactions in the Pathogenesis of Lupus Nephritis: The Role of T Cells and Macrophages in the Amplification of the Inflammatory Process in the Kidney</article-title>. <source>Lupus</source> (<year>1998</year>) <volume>7</volume>(<issue>9</issue>):<fpage>597</fpage>&#x2013;<lpage>603</lpage>. doi: <pub-id pub-id-type="doi">10.1191/096120398678920712</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>PM</given-names>
</name>
<name>
<surname>Wilson</surname> <given-names>PC</given-names>
</name>
<name>
<surname>Shyer</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Veselits</surname> <given-names>M</given-names>
</name>
<name>
<surname>Steach</surname> <given-names>HR</given-names>
</name>
<name>
<surname>Cui</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Kidney Tissue Hypoxia Dictates T Cell-Mediated Injury in Murine Lupus Nephritis</article-title>. <source>Sci Transl Med</source> (<year>2020</year>) <volume>12</volume>(<issue>538</issue>):<elocation-id>eaay1620</elocation-id>. doi: <pub-id pub-id-type="doi">10.1126/scitranslmed.aay1620</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>J</given-names>
</name>
<name>
<surname>Jeong</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Jung</surname> <given-names>J</given-names>
</name>
<name>
<surname>Jeon</surname> <given-names>H</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lim</surname> <given-names>JS</given-names>
</name>
<etal/>
</person-group>. <article-title>Immunological Characteristics and Possible Pathogenic Role of Urinary CD11c+ Macrophages in Lupus Nephritis</article-title>. <source>Rheumatol (Oxford)</source> (<year>2020</year>) <volume>59</volume>(<issue>8</issue>):<page-range>2135&#x2013;45</page-range>. doi: <pub-id pub-id-type="doi">10.1093/rheumatology/keaa053</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Foell</surname> <given-names>D</given-names>
</name>
<name>
<surname>Wittkowski</surname> <given-names>H</given-names>
</name>
<name>
<surname>Vogl</surname> <given-names>T</given-names>
</name>
<name>
<surname>Roth</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>S100 Proteins Expressed in Phagocytes: A Novel Group of Damage-Associated Molecular Pattern Molecules</article-title>. <source>J Leukoc Biol</source> (<year>2007</year>) <volume>81</volume>:<fpage>28</fpage>&#x2013;<lpage>37</lpage>. doi: <pub-id pub-id-type="doi">10.1189/jlb.0306170</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frosch</surname> <given-names>M</given-names>
</name>
<name>
<surname>Vogl</surname> <given-names>T</given-names>
</name>
<name>
<surname>Waldherr</surname> <given-names>R</given-names>
</name>
<name>
<surname>Sorg</surname> <given-names>C</given-names>
</name>
<name>
<surname>Sunderk&#xf6;tter</surname> <given-names>C</given-names>
</name>
<name>
<surname>Roth</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Expression of MRP8 and MRP14 by Macrophages Is a Marker for Severe Forms of Glomerulonephritis</article-title>. <source>J Leukoc Biol</source> (<year>2004</year>) <volume>75</volume>(<issue>2</issue>):<fpage>198</fpage>&#x2013;<lpage>206</lpage>. doi: <pub-id pub-id-type="doi">10.1189/jlb.0203076</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benjachat</surname> <given-names>T</given-names>
</name>
<name>
<surname>Tongyoo</surname> <given-names>P</given-names>
</name>
<name>
<surname>Tantivitayakul</surname> <given-names>P</given-names>
</name>
<name>
<surname>Somparn</surname> <given-names>P</given-names>
</name>
<name>
<surname>Hirankarn</surname> <given-names>N</given-names>
</name>
<name>
<surname>Prom-On</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Biomarkers for Refractory Lupus Nephritis: A Microarray Study of Kidney Tissue</article-title>. <source>Int J Mol Sci</source> (<year>2015</year>) <volume>16</volume>(<issue>6</issue>):<page-range>14276&#x2013;90</page-range>. doi: <pub-id pub-id-type="doi">10.3390/ijms160614276</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davies</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Midgley</surname> <given-names>A</given-names>
</name>
<name>
<surname>Carlsson</surname> <given-names>E</given-names>
</name>
<name>
<surname>Donohue</surname> <given-names>S</given-names>
</name>
<name>
<surname>Bruce</surname> <given-names>IN</given-names>
</name>
<name>
<surname>Beresford</surname> <given-names>MW</given-names>
</name>
<etal/>
</person-group>. <article-title>Urine and Serum S100A8/A9 and S100A12 Associate With Active Lupus Nephritis and may Predict Response to Rituximab Treatment</article-title>. <source>RMD Open</source> (<year>2020</year>) <volume>6</volume>(<issue>2</issue>):<elocation-id>e001257</elocation-id>. doi: <pub-id pub-id-type="doi">10.1136/rmdopen-2020-001257</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tantivitayakul</surname> <given-names>P</given-names>
</name>
<name>
<surname>Benjachat</surname> <given-names>T</given-names>
</name>
<name>
<surname>Somparn</surname> <given-names>P</given-names>
</name>
<name>
<surname>Leelahavanichkul</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kittikovit</surname> <given-names>V</given-names>
</name>
<name>
<surname>Hirankarn</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>Elevated Expressions of Myeloid-Related Proteins-8 and -14 are Danger Biomarkers for Lupus Nephritis</article-title>. <source>Lupus</source> (<year>2016</year>) <volume>25</volume>(<issue>1</issue>):<fpage>38</fpage>&#x2013;<lpage>45</lpage>. doi: <pub-id pub-id-type="doi">10.1177/0961203315598015</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>B</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Jiao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>S100a8/a9 Signaling Causes Mitochondrial Dysfunction and Cardiomyocyte Death in Response to Ischemic/Reperfusion Injury</article-title>. <source>Circulation</source> (<year>2019</year>) <volume>140</volume>(<issue>9</issue>):<page-range>751&#x2013;64</page-range>. doi: <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.118.039262</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>